There has been another new development in the growing number of blood pressure and heart medication recalls as Camber Pharmaceuticals announced a recall of 87 lots of Losartan Potassium for having too much NMBA. Torrent recalled 60 lots of Losartan potassium tablets and 54 lots of Losartan potassium/hydrochlorothiazide tablets because of NMBA’s presence. The active ingredient in each came from India-based Hetero Labs Limited.
NMBA, a known carcinogen is different than NDMA, which has been the cause of previous Losartan, Valsartan and Irbesartan recalls. The FDA began issuing the recalls for these drugs last year after discovering NDEA in a number of the blood pressure and heart medications. The chemical is a known carcinogen that is used as a stabilizer in gasoline and rocket fuel. NDEA is also a byproduct of manufacturing some pesticides and fish. This impurity has been known to cause tumors in various organs, including the liver and kidney.
At Saunders & Walker we urge that if your drug is on the recall list, please consult your physician or pharmacist to find out if you need a replacement. Also please note that that the FDA suggests you continue taking your current medication until a replacement can be provided.
If you or a loved one took Irbesartan or Valsartan and have been diagnosed with cancer, pleas contact Saunders & Walker at 1-800-748-7115 for a free consultation and learn more about case eligibility and whether you may be entitled to financial compensation.
Latest posts by Joseph Saunders (see all)
- NY Times Slams FDA Over Faulty Medical Devices - May 6, 2019
- Diocese of Sacramento Releases List of Priests Who Abused Children - April 30, 2019
- Diocese of Allentown Opens Compensation Plan for Survivors of Abuse - April 26, 2019